Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-06

FDA Approved: DAPSONE — Original Application (Trupharma, LLC)

View source ↗

Summary

FDA approved the generic DAPSONE GEL, 5% (dapsone gel) from Trupharma, LLC under an Original Application (ANDA 213907).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DAPSONE GEL, 5% (dapsone gel, 5%)

Snippet

ORIG AP for DAPSONE (DAPSONE GEL, 5%)